Alendronic Acid, Federal Supreme Court (Bundesgericht), 4 March 2011
Patentability of an invention is not excluded by the mere fact that the only feature of the patent claim not comprised in the state of the art is a dosage regime. Click here for the full text of this case. A full summary of this case has been published on Kluwer IP Law.